Kiniksa Pharmaceuticals
Manufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
100 Hayden Ave, Lexington, Massachusetts...Phone Number
(781) 431-9100Website
www.kiniksa.comRevenue
$840.8 MillionStock Symbol
KNSAIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals, founded in 2015 and headquartered in Hamilton, Bermuda, is a biopharmaceutical company dedicated to the discovery, acquisition, development, and commercialization of therapeutic medicines. The company specializes in diagnostic and health services, focusing on innovative treatments for various medical conditions. With operations across North America and Europe, Kiniksa Pharmaceuticals maintains a strong presence in the healthcare industry through its commitment to advancing medical solutions and therapeutic technologies. The company is publicly traded and continues to expand its portfolio of pharmaceutical products aimed at addressing unmet medical needs.Explore more
Kiniksa Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kiniksa Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Kiniksa Pharmaceuticals had a recent Job posting/layoffs
Check out if Kiniksa Pharmaceuticals is spiking on competitors!
Kiniksa Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Kiniksa Pharmaceuticals has new funding data
Check if Kiniksa Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Kiniksa Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Kiniksa Pharmaceuticals
Product Launch: Get notified when Kiniksa Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Kiniksa Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Kiniksa Pharmaceuticals
Compare insights from companies similar to Kiniksa Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kiniksa Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kiniksa Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals Tech Stack
A closer look at the technologies used by Kiniksa Pharmaceuticals
See more technologies
Most Recent Scoops
Person-Based
Digital Marketing, Advertising, Marketing Campaign
Earnings
Kiniksa Pharmaceuticals has reported a year-to-date gross-to-net rate of 7.2% as of Q2 2026, down from 8.6% in Q1 2026, primarily driven by lower co-pay support costs following changes made to the support program at the beginning of the year, with gross-to-net expected to follow its historical seasonal pattern of being highest in Q1, lower in Q2 and Q3, and slightly higher in Q4.
Earnings, Accounting, Financial Reporting, Finance
Earnings
Kiniksa Pharmaceuticals has raised its full-year 2026 revenue guidance from a range of $930 million to $945 million to a revised range of $980 million to $995 million.
Earnings, Forecasting, Finance
Project
Kiniksa Pharmaceuticals has launched a targeted direct-to-consumer campaign called "Heart's Home," aimed at educating and empowering recurrent pericarditis patients to visit their healthcare professional and ask for ARCALYST, which has reached thousands of patients since its April 2026 launch and is showing early signs of patient engagement.
Customer Engagement, Marketing Campaign, Healthcare Operations
Earnings
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kiniksa Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Kiniksa Pharmaceuticals, founded in 2015 and headquartered in Hamilton, Bermuda, is a biopharmaceutical company dedicated to the discovery, acquisition, development, and commercialization of therapeutic medicines. The company specializes in diagnostic and health services, focusing on innovative treatments for various medical conditions. With operat... Read More
